Viking Therapeutics, Inc. (VKTX)
33.52
-0.40
(-1.18%)
USD |
NASDAQ |
Jan 20, 16:00
33.56
+0.04
(+0.12%)
After-Hours: 05:09
Viking Therapeutics EPS Diluted (Quarterly): -0.8083 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Amgen, Inc. | 5.934 |
| Altimmune, Inc. | -0.2126 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -90.79M |
| Total Expenses (Quarterly) | 90.79M |
| Enterprise Value | 3.075B |
| Earnings Yield | -6.32% |
| Normalized Earnings Yield | -6.320 |